Method of Screening Cancer Cells Using Wrinkle Patterns on a Thin Membrane

Patent metadata

Field	Value
Publication number	US-2017191989-A1
Application number	US-201515316710-A
Country	US
Kind code	A1
Filing date	Jun 9, 2015
Priority date	Jun 9, 2014
Publication date	Jul 6, 2017
Grant date	—

Abstract

Systems and methods for performing cancer screening assays are disclosed. The disclosed systems and methods use a thin film comprising cross-linked polysiloxane. At least a portion of a biological sample to be assayed is contacted with the thin film, along with a cell culture media. After a subsequent incubation period, the thin film is visualized to detect a wrinkle pattern (or lack thereof). The presence of one or more wrinkles and/or a higher degree of wrinkling in the thin film indicates the presence of cancer cells in the biological sample. The disclosed systems and methods can be incorporated into improved assays and kits for cancer screening.

First claim

1 . A method for detecting the presence of one or more cancer cells in a biological sample, the method comprising:
contacting a thin film comprising a cross-linked polysiloxane with at least a portion of a biological sample and a culture media; and detecting the presence or absence of one or more wrinkles in the thin film, whereby the presence of one or more wrinkles indicates that the biological sample contains one or more cancer cells.

2 . The method of claim 1 , wherein the cross-linked polysiloxane is a cross-linked polydimethylsiloxane.

3 . The method claim 2 , wherein the cross-linked polydimethylsiloxane is a cross-linked liquid silicone.

4 . The method of claim 1 , wherein the polysiloxane is cross-linked by heating the polysiloxane.

5 . The method of claim 1 - 4 , wherein the thin film is between 5 nm and 1,000 nm thick.

6 . The method of claim 5 , wherein the thin film is between 5 nm and 500 nm thick.

7 . The method of claim 6 , wherein the thin film is between 5 nm and 100 nm thick.

8 . The method of claim 7 , wherein the thin film is between 10 nm and 50 nm thick.

9 . The method of claim 1 - 8 , wherein the step of detecting the presence or absence of one or more wrinkles in the thin film is performed by visually inspecting the thin film.

10 . The method of claim 9 , wherein the step of visually inspecting the thin film is performed using conventional light microscopy.

11 . The method of claim 1 , wherein the cancer cells are bladder cancer cells.

12 . The method of claim 1 , wherein the biological sample comprises a fluid selected from the group consisting of urine, blood, saliva, lymph, and cerebrospinal fluid.

13 . A method of screening for cancer in a subject, the method comprising:
contacting a thin film comprising a cross-linked polysiloxane with a culture media and at least a portion of a biological sample obtained from the subject; and detecting the wrinkle pattern of the thin film, whereby the nature of the wrinkle pattern indicates the potential presence of cancer in the subject.

14 . The method of claim 13 , wherein the polysiloxane is cross-linked by heating the polysiloxane.

15 . The method of claim 13 , wherein the wrinkle pattern is detected by visualizing the thin film.

16 . The method of claim 15 , wherein the thin film is visualized using conventional light microscopy.

17 . The method of claim 13 , wherein the wrinkle pattern is quantitatively measured.

18 . The method of claim 17 , wherein a higher quantity of wrinkles in the wrinkle pattern indicates a higher likelihood of the subject having cancer.

19 . The method of claim 17 , wherein a longer length of wrinkles in the wrinkle pattern indicates a higher likelihood of the subject having cancer.

20 . The method of claim 13 , wherein the cross-linked polysiloxane is a cross-linked polydimethylsiloxane.

21 . The method claim 20 , wherein the cross-linked polydimethylsiloxane is a cross-linked liquid silicone.

22 . The method of claim 13 , wherein the thin film is between 5 nm and 1,000 nm thick.

23 . The method of claim 22 , wherein the thin film is between 5 nm and 500 nm thick.

24 . The method of claim 23 , wherein the thin film is between 5 nm and 100 nm thick.

25 . The method of claim 24 , wherein the thin film is between 10 nm and 50 nm thick.

26 . The method of claim 13 , wherein the type of cancer that is screened for is bladder cancer.

27 . The method of claim 13 , wherein the biological sample comprises a fluid selected from the group consisting of urine, blood, saliva, lymph, and cerebrospinal fluid.

28 . A kit for performing a cancer screening assay, the kit comprising:
a thin film having a thickness of from 5 nm to 500 nm comprising a cross-linked polysiloxane; and a media for culturing cells.

29 . The method of claim 28 , wherein the cross-linked polysiloxane is a cross-linked polydimethylsiloxane.

30 . The method claim 29 , wherein the cross-linked polydimethylsiloxane is a cross-linked liquid silicone.

31 . The method of claim 28 , wherein the thin film is between 5 nm and 100 nm thick.

32 . The method of claim 31 , wherein the thin film is between 10 nm and 50 nm thick.

Assignees

• Univ Arizona State

Inventors

• Chae Junseok
• Appel Jennie
• Liao Joseph

Classifications

• G01N33/575

  for cancer · CPC title

• G01N21/8422

  Investigating thin films, e.g. matrix isolation method · CPC title

• G01N33/5091 Primary

  for testing the pathological state of an organism · CPC title

• G01N33/487 Primary

  of liquid biological material · CPC title